
### [NCIT:C9388](http://purl.obolibrary.org/obo/NCIT_C9388)
**Label:** Sarcoma NCI Grade 1

**Subclasses:** [NCIT:C27489](http://purl.obolibrary.org/obo/NCIT_C27489) (Spindle Cell Liposarcoma), [NCIT:C9389](http://purl.obolibrary.org/obo/NCIT_C9389) (Well Differentiated Leiomyosarcoma), [NCIT:C6508](http://purl.obolibrary.org/obo/NCIT_C6508) (Inflammatory Liposarcoma), [NCIT:C9025](http://purl.obolibrary.org/obo/NCIT_C9025) (Well Differentiated Fibrosarcoma), [NCIT:C4250](http://purl.obolibrary.org/obo/NCIT_C4250) (Well Differentiated Liposarcoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36105](http://purl.obolibrary.org/obo/NCIT_C36105) (Indolent Clinical Course) 56.25%
- [NCIT:C28077](http://purl.obolibrary.org/obo/NCIT_C28077) (Grade 1) 56.25%
- Thing 52.26%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) 41.61%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 41.61%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 41.61%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 41.61%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 41.61%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 41.61%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 41.61%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 41.61%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 41.61%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 41.61%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 41.61%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 41.61%


